SANUWAVE Health, Inc. SNWV R2K
Healthcare · Medical Devices · United States
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
READ MORE ›$16.47
-37.14% 1Y
Market & Price
Market Cap
$141.63M
Current Price
$16.47
High / Low (52W)
$45.00 / $15.57
Beta
1.36
Valuation
Stock P/E
17.16
Industry PE
23.65
Forward P/E
-
PEG Ratio
-
Book Value
$0.19
Price to Book
87.61
P/S
3.19
EV/EBITDA
26.17
Dividend Yield
-
Profitability & Returns
ROCE
93.07%
ROE
-
ROA
8.81%
Profit Margin
37.20%
Op Margin
-11.68%
EPS (Latest Qtr)
$-0.17
EPS (TTM)
$0.96
Balance Sheet & Liquidity
Debt/Equity
12.06
Quick Ratio
0.92
Current Ratio
1.31
Debt
$22.16M
Total Assets
$37.34M
Current Assets
$24.63M
Working Capital
$6.78M
Ownership
Promoter Holding
1.31%
Chg in Prom Hold
-
FII / Inst Holding
47.24%
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
$153.01M
Total Revenue (TTM)
$44.34M
EBITDA
$5.85M
Free Cash Flow
$-5.50M
Operating Cash Flow
$5.79M
Shares Outstanding
8.60M
Gross Margin
76.74%
Payout Ratio
0.00%
Growth (CAGR)
Revenue 5Y
38.05%
Profit 5Y
71.59%
Revenue (YoY)
3.10%
Earnings (YoY)
-
PROS
- Healthy ROCE of 93.1%.
- Excellent profit margin of 37.2%.
- Compounding revenue at 38.1% over 5 years.
- Profit CAGR of 71.6% over 5 years.
CONS
- Trading 63.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SNWV SANUWAVE Health, Inc. R2K | 16.47 | 17.16 | $141.63M | - | 93.07% | - | 38.05% | 71.59% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 197.64K | 149.00K | 83.00K | 1.37M | 1.86M | 2.63M | 3.73M | 2.85M | 3.54M | 3.92M | 3.49M | 4.41M | 4.82M | 5.68M | 7.08M | - | - | 9.33M | 10.16M | 11.45M | 13.09M | 9.62M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.96M | 2.21M | 2.53M | 3.39M | 2.19M |
| Gross Profit | 118.95K | 126.76K | 174.72K | 159.41K | 151.63K | 164.20K | 104.85K | 196.14K | 125.42K | 156.97K | - | - | 99.90K | 178.81K | 286.57K | 412.19K | 84.11K | 131.09K | 74.72K | 19.00K | 4.00K | 765.00K | 1.06M | 1.86M | 2.17M | 2.31M | 2.79M | 3.01M | 2.51M | 3.47M | 3.54M | 4.20M | 5.24M | - | - | 7.38M | 7.96M | 8.93M | 9.70M | 7.43M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.77M | 6.08M | 7.46M | 9.09M | 8.55M |
| Operating Income | -1.89M | -2.02M | -1.61M | -1.41M | -1.13M | -1.01M | -1.32M | -689.47K | -1.02M | -833.61K | -620.64K | -1.31M | -647.78K | -1.12M | -2.12M | -2.67M | -1.86M | -2.02M | -2.39M | -2.80M | -3.27M | -6.37M | -4.39M | -4.05M | -3.33M | -1.96M | -3.05M | -2.48M | -1.98M | 931.00K | -531.00K | -1.29M | 1.65M | - | - | 601.00K | 1.88M | 1.47M | 615.00K | -1.12M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.94M | 3.23M | 12.27M | 7.64M | -581.00K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.91M | 1.87M | 1.72M | 798.00K | 546.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.12M | 1.05M | 10.32M | 6.20M | -1.44M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -4.44M | -2.56M | -1.69M | -1.49M | -1.16M | -1.52M | -1.03M | -1.72M | -1.12M | -1.14M | -493.53K | -1.42M | -851.33K | -5.86M | -2.89M | -825.14K | -2.20M | -2.73M | -2.75M | -3.00M | -3.63M | -12.64M | -4.94M | -8.62M | -4.25M | -5.10M | 1.64M | -1.14M | -13.08M | -7.26M | -23.70M | -4.80M | 6.19M | - | - | -6.12M | 1.05M | 10.32M | 6.11M | -1.44M |
| Diluted EPS | -0.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.01 | -0.01 | -0.03 | -0.01 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 | -0.02 | -0.01 | -9.95 | 0.00 | 0.00 | - | -1.49 | -0.72 | 0.01 | 0.46 | - | -0.17 |
| R&D Expense | 775.72K | 764.85K | 1.01M | 708.30K | 634.62K | 456.79K | 569.13K | 309.95K | 476.17K | 266.47K | 260.34K | 437.91K | 266.84K | 238.48K | 328.75K | 622.15K | 261.00K | 307.27K | 299.90K | 287.00K | 265.00K | 432.00K | 354.00K | 272.00K | 297.00K | 166.00K | 171.00K | 157.00K | 131.00K | 139.00K | 165.00K | 163.00K | 195.00K | 161.00K | - | 208.00K | 194.00K | 345.00K | - | 660.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 1.03M | 3.63M | - | 16.74M | 20.40M | 32.63M | 44.05M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 4.33M | 6.04M | 8.08M | 10.08M |
| Gross Profit | 478.12K | 540.68K | 548.96K | 610.24K | 627.39K | 680.54K | - | 496.56K | 1.16M | 489.81K | 2.90M | - | 12.41M | 14.36M | 24.55M | 33.97M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 21.36M | 14.90M | 20.70M | 29.02M |
| Operating Income | -11.81M | -8.81M | -6.06M | -5.98M | -5.96M | -4.44M | -3.32M | -3.82M | -7.18M | -8.79M | -25.20M | - | -8.95M | -540.00K | 3.85M | 4.95M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | 4.79M | -9.15M | -18.13M | 19.43M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | 14.13M | 15.62M | 13.78M | 6.25M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | -10.29M | -25.80M | -33.06M | 11.90M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | 2.00K | 4.00K | 27.00K | 86.00K |
| Net Income | -14.92M | -10.24M | -6.40M | -11.30M | -5.97M | -4.81M | -6.44M | -5.54M | -11.63M | -10.43M | -30.94M | - | -10.29M | -25.81M | -33.08M | 11.81M |
| Diluted EPS | -1.15 | -0.52 | -0.30 | - | - | - | - | - | - | -0.05 | -0.08 | - | -7.50 | -12.19 | -7.03 | 0.41 |
| R&D Expense | 3.88M | 2.73M | 1.76M | 2.30M | 3.00M | 2.17M | 1.13M | 1.29M | 981.65K | 1.18M | 1.25M | 1.10M | 567.00K | 579.00K | 673.00K | 1.35M |
Compounded Sales Growth
| 5 Years: | 38.05% |
| 1 Year: | 3.10% |
Compounded Profit Growth
| 5 Years: | 71.59% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -37.14% |
| 6 Months: | -52.98% |
| 3 Months: | -32.29% |
| 1 Month: | -0.84% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Dec 2023 | Jan 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 3.03M | 6.17M | 1.85M | 1.59M | 4.67M | 958.36K | 1.00M | 1.28M | 1.18M | 3.38M | 23.03M | - | 17.01M | 17.84M | 18.78M | 19.87M | 22.42M | - | 30.12M | - | - | - | 37.34M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.62M | 9.78M | - | 18.40M | - | - | - | 24.63M |
| Cash & Equivalents | 1.79M | 417.46K | 3.91M | 70.33K | 182.31K | 3.55M | 152.93K | 133.57K | 730.18K | 364.55K | 1.76M | 2.44M | - | 313.00K | 1.48M | 1.11M | 1.15M | 1.80M | - | 10.24M | - | - | - | 11.96M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 868.00K | 2.95M | - | 4.15M | - | - | - | 5.93M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.03M | 3.31M | - | 3.33M | - | - | - | 5.42M |
| Total Liabilities | - | 13.55M | 7.70M | 8.37M | 7.72M | 6.22M | 6.84M | 7.92M | 11.16M | 16.53M | 13.45M | 36.74M | - | 55.08M | 53.38M | 54.09M | 60.88M | 65.59M | 66.96M | 45.91M | 51.67M | 51.84M | 43.19M | 35.72M |
| Current Liabilities | - | 8.17M | 2.32M | 2.99M | 2.34M | 6.22M | 1.49M | 7.92M | 11.16M | 16.49M | 12.42M | 36.17M | - | 53.91M | 52.25M | 53.59M | 60.22M | 64.75M | - | 45.42M | 50.78M | 50.42M | 23.98M | 17.85M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 143.00K | 875.00K | - | - | - | - | - | - | - | - | - | - | 16.32M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 38.98M | 30.45M | - | 25.80M | - | - | - | 22.97M |
| Total Equity | - | -10.52M | -1.54M | -6.52M | -6.13M | -1.55M | -5.88M | -6.91M | -9.88M | -15.36M | -10.06M | -13.72M | - | -38.07M | -35.53M | -35.31M | -41.01M | -43.18M | -44.55M | -15.79M | -20.81M | -18.80M | -7.59M | 1.62M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.46M | 3.04M | - | 8.54M | - | - | - | 8.59M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.87M | -8.83M | -4.29M | -3.92M | -6.68M | -3.47M | -3.20M | -1.53M | -3.62M | -6.41M | -12.72M | - | -17.17M | -4.54M | 2.46M | 3.88M |
| Investing Cash Flow | 7.00K | -42.30K | -2.01K | 7.50K | -8.86K | 100.00K | -8.77K | 0 | -42.89K | -53.94K | -20.05M | - | 332.00K | 21.00K | -490.00K | 3.43M |
| Financing Cash Flow | 4.50M | 12.37M | 450.42K | 4.04M | 10.07M | - | 3.21M | 2.12M | 3.32M | 7.86M | 33.45M | - | 17.38M | 5.21M | 6.35M | -5.59M |
| Capital Expenditure | - | -42.30K | -2.01K | - | -8.86K | - | -10.36K | -0 | -42.89K | -53.94K | -53.00K | -529.00K | - | - | -490.00K | -1.94M |
| Free Cash Flow | - | -8.87M | -4.29M | - | -6.69M | - | -3.21M | -1.53M | -3.66M | -6.46M | -12.77M | - | -17.17M | -4.54M | 1.97M | 1.93M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | 547.00K | 694.00K | 8.32M | 1.72M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | 47.6% | 79.8% | - | 74.1% | 70.4% | 75.2% | 77.1% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | -854.9% | -694.6% | - | -53.5% | -2.6% | 11.8% | 11.2% |
| Net Margin % | - | - | - | - | - | - | - | - | - | -1,013.9% | -852.7% | - | -61.5% | -126.5% | -101.4% | 26.8% |
| ROE % | 141.9% | 666.4% | 98.2% | 184.4% | 385.1% | 81.8% | 93.2% | 56.0% | 75.7% | 103.6% | 225.5% | - | 25.1% | 59.8% | 209.5% | 729.6% |
| ROCE % | 229.6% | -229.1% | 530.7% | 791.4% | 384.4% | 837.8% | 48.0% | 38.7% | 46.9% | 97.4% | 191.7% | - | 22.2% | 1.3% | -25.1% | 25.4% |
Shareholding Pattern
Insiders
1.31%
Institutions
47.24%
Public Float
47.86%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Opaleye Management Inc. | 11.48% | 981.27K | $16.16M |
| 2 | Blackrock Inc. | 5.63% | 481.54K | $7.93M |
| 3 | AWM Investment Company, Inc. | 5.32% | 454.55K | $7.49M |
| 4 | Praetorian PR LLC | 4.10% | 350.00K | $5.76M |
| 5 | Vanguard Capital Management LLC | 4.08% | 348.87K | $5.75M |
| 6 | Solas Capital Management, LLC | 3.36% | 287.51K | $4.74M |
| 7 | Stifel Financial Corporation | 2.94% | 251.63K | $4.14M |
| 8 | UBS Group AG | 2.46% | 210.26K | $3.46M |
| 9 | Geode Capital Management, LLC | 2.01% | 171.80K | $2.83M |
| 10 | State Street Corporation | 1.64% | 140.09K | $2.31M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SNWV
No recent headlines available.